RNAiスクリーンは, Brd4 を急性骨髄性白血病の治療標的として識別します
Johannes Zuber1, Junwei Shi, Eric Wang
1Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, New York 11724, USA.
Nature
|August 5, 2011
まとめ
研究者らは,ブロモドメイン含有4 (Brd4) を,急性骨髄性白血病 (AML) の主要な調節因子として特定した. Brd4をJQ1で阻害することで,がん幹細胞を標的とし,有望な治療戦略を提供することで,有意な抗白血病効果が示されました.
科学分野:
- エピジェネティクス エピジェネティクス
- がん生物学 がん生物学
- 血液学 ヘマトロジ
背景:
- 癌細胞は,腫瘍性遺伝子発現のための表遺伝子調節体を操作する.
- エピジェネティック経路をターゲットにすることは有望ですが,がん特異的な依存性の不完全な理解によって制限されています.
- 急性骨髄性白血病 (AML) は,しばしば異常な染色体状態を特徴としています.
研究 の 目的:
- 無偏見のスクリーニングアプローチを使用して,AMLにおける表遺伝的脆弱性を特定する.
- AML疾患の維持におけるクロマチン調節体の役割を調査する.
- 特定された脆弱性へのターゲティングによる治療の可能性を評価する.
主な方法:
- AMLマウスモデルにおけるクロマチンの調節体を標的とする小さなヘアピンRNA (shRNA) のスクリーニング.
- 小分子阻害剤JQ1を用いて,ブロモドメイン含有4 (Brd4) を抑制する.
- 抗白血病効果の評価 in vitroおよびin vivo,白血病幹細胞およびヒトAMLサンプルへの効果を含む.
主要な成果:
- ブロモドメイン含有4 (Brd4) は,AMLの維持に重要なものとして特定されました.
- shRNAまたはJQ1を用いたBrd4の抑制は,強力な抗白血病効果と末期骨髄膜分化を引き起こす.
- JQ1は,MYC発現を抑制することによって,多様なヒトAMLサブタイプにわたる広範な活性を示しました.
結論:
- Brd4をJQ1のような小分子で標的にすることは,AMLに対する有望な治療戦略です.
- Brd4の阻害は,がんにおけるMYC腫瘍遺伝子を抑制する方法を提供します.
- RNA干渉 (RNAi) スクリーニングは,薬の開発における表遺伝的脆弱性を発見するのに有効です.
関連する概念動画
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Types of RNA
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...


